By analyzing the methylation profiles, the methylation status of the ADAM17 promoter in BLCA, READ, and THCA tumor tissues was distinctly lower than in adjacent normal tissues, whereas its methylation status was higher in BRCA, KIRC, KIRP, LUSC, PAAD, PRAD, SARC, and SKCM tumor tissues. This evidence concerns the gene ADAM17 and reading.